二十年来影像检查自付费用变化:基于全国患者调查的纵向研究
该研究利用2000至2019年美国医疗支出面板调查数据,纳入102,717例患者共229,010次影像相关就诊,分析乳腺X线、X线、超声及CT/MR的平均总费用与自付费用变化。结果显示总体平均自付费用二十年间增长89.8%,其中X线、超声和CT/MR自付费用分别增长81%、123.2%和61%,而乳腺X线自付费用下降32.9%。无保险、较年轻、有癌症史及合并症者自付费用更高。
要点
- 影像检查总体平均自付费用二十年间增长89.8%,需关注患者经济负担。
- 超声和X线自付费用增幅最大(123.2%和81%),CT/MR增长61%。
- 无保险、年轻、癌症史及合并症患者自付费用更高,报告时可提示费用咨询。
核心结论
- 过去二十年影像检查平均总体患者自付费用显著且大幅增加。
- 无保险、较年轻、有癌症史及其他合并症与更高的自付费用相关。
- 随着诊断影像使用增加,患者经济困难问题值得进一步关注。
研究设计与样本
- 研究类型为基于全国调查的纵向回顾性分析,使用2000至2019年医疗支出面板调查数据。
- 共纳入102,717例患者(平均45.6岁;64.8%女性;58.8%白人),对应229,010次影像相关就诊。
- 影像检查包括乳腺X线、X线、超声及CT/MR(调查中合并记录),计算平均总体费用和自付费用,并采用logistic回归和广义线性模型分析影响因素。
诊断标准与关键数值
- 2000至2019年,乳腺X线、X线和超声的平均总费用分别增加14.5%、24.5%和40%,CT或MR总平均费用下降15.1%。
- 51%的就诊产生自付费用;总体平均自付费用从2000至2019年增加89.8%。
- 乳腺X线平均自付费用下降32.9%;X线、超声和CT或MR平均自付费用分别增加81%、123.2%和61%。
临床应用与阅片要点
- 阅片和报告流程中可关注患者保险状态和合并症,对无保险、年轻及有癌症史者提示可能的经济负担。
- 乳腺X线自付费用下降而超声和X线自付费用大幅上升,费用咨询时可据此提供信息。
局限性
- 研究为基于调查数据的回顾性分析,CT与MR在调查中合并记录,无法区分二者费用。
- 原文未报告多中心情况、设备或序列信息,也未涉及影像征象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Using national surveys, we longitudinally studied imaging costs-and specifically those paid out-of-pocket (OOP) by patients-over two decades.
METHODS: Using 2000 to 2019 Medical Expenditure Panel Survey data, we identified all imaging-focused encounters (mammography, radiography, ultrasonography, and CT and MR [surveyed together in Medical Expenditure Panel Survey]) and calculated mean overall and OOP encounter costs. Effects of sociodemographic, personal, and clinical factors were measured using logistic regression and generalized linear modeling.
RESULTS: We identified 102,717 patients (mean 45.6 years; 64.8% female; 58.8% White) undergoing 229,010 imaging-focused encounters. Between 2000 and 2019, mean costs of mammography, radiography, and ultrasonography increased 14.5%, 24.5%, and 40% and total mean cost of CT or MR decreased by 15.1%. OOP costs were incurred by 51%. Overall mean OOP costs increased 89.8% from 2000 to 2019. Mean OOP costs for mammography decreased by 32.9%; mean OOP costs for radiography, ultrasonography, and CT or MR increased 81%, 123.2%, and 61%, respectively. Patients were less likely to incur OOP costs when older, of racial and ethnic minorities, female, or recipients of public only (versus private) insurance. Among those with OOP costs, the presence of comorbidities, lack of insurance, younger age, and history of cancer significantly increased OOP costs.
CONCLUSION: Mean overall patient OOP costs for imaging examinations increased significantly and substantially over the last two decades. Lack of insurance, younger age, history of cancer, and other comorbidities were associated with higher OOP costs. As diagnostic imaging utilization increases, patient financial hardship considerations merit further attention.
引用
- Choksi, Mukherjee, Sadigh, et al. Out-of-Pocket Expenditures for Imaging Examinations: Perspectives From National Patient Surveys Over Two Decades. J Am Coll Radiol. 2022. PMID: 36210041. doi:10.1016/j.jacr.2022.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。